Sign in

CIK 0001157601

  • Large accelerated filer

MADRIGAL PHARMACEUTICALS, INC.

Sign in to watch
Ticker
MDGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 267-824-2827
Business address
1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
Former names
MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
Open-market buys, last 90 days
$35,023,032
in 1 filing
Open-market sales, last 90 days
$6,669,998
in 2 filings, $6.7M under 10b5-1 plans

Net +$28,353,034. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2016-07-22 Schor Chen Former President and CEO Grant or award +42,857 51,428
2016-07-22 Schor Chen Former President and CEO Shares withheld for taxes −14,250 $9.48 $135K 37,178
2015-10-02 Schor Chen President and CEO Grant or award · Employee Stock Option (Right to Buy) +250,000 250,000
2015-09-16 Schor Chen President and CEO Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000
2015-06-05 Schor Chen President and CEO Grant or award +150,000 300,000
2015-06-05 Schor Chen President and CEO Grant or award · Employee Stock Option (Right to Buy) +500,000 500,000
2014-12-08 Schor Chen Executive VP and COO Grant or award +150,000 150,000
2014-12-08 Schor Chen Executive VP and COO Grant or award · Employee Stock Option (Right to Buy) +450,000 450,000

Page 1 of 1 · 8 trades